TY  - JOUR
AU  - Lago, Santiago G
AU  - Tomasik, Jakub
AU  - van Rees, Geertje F
AU  - Rubey, Marina
AU  - Gonzalez-Vioque, Emiliano
AU  - Ramsey, Jordan M
AU  - Haenisch, Frieder
AU  - Broek, Jantine A
AU  - Vázquez-Bourgon, Javier
AU  - Papiol, Sergi
AU  - Suarez-Pinilla, Paula
AU  - Ruland, Tillmann
AU  - Auyeug, Bonnie
AU  - Mikova, Olya
AU  - Kabacs, Nikolett
AU  - Arolt, Volker
AU  - Baron-Cohen, Simon
AU  - Crespo-Facorro, Benedicto
AU  - Bahn, Sabine
PY  - 2020
DO  - 10.1016/j.bbi.2020.07.043
UR  - http://hdl.handle.net/10668/16227
T2  - Brain, behavior, and immunity
AB  - Recent evidence suggests that comorbidities between neuropsychiatric conditions and metabolic syndrome may precede and even exacerbate long-term side-effects of psychiatric medication, such as a higher risk of type 2 diabetes and cardiovascular...
LA  - en
KW  - Antipsychotic treatment
KW  - Cell surface marker
KW  - Flow cytometry
KW  - Homeostasis model assessment
KW  - Insulin sensitivity
KW  - Metabolic syndrome
KW  - Neuropsychiatric conditions
KW  - Peripheral blood mononuclear cell
KW  - Polygenic risk score
KW  - Response prediction
KW  - Weight gain
KW  - Antipsychotic Agents
KW  - Diabetes Mellitus, Type 2
KW  - Humans
KW  - Leukocytes, Mononuclear
KW  - Metabolic Syndrome
KW  - Schizophrenia
TI  - Exploring cellular markers of metabolic syndrome in peripheral blood mononuclear cells across the neuropsychiatric spectrum.
TY  - research article
VL  - 91
ER  -